Quick answer
Semaglutide is the active ingredient in Wegovy, which is FDA approved for chronic weight management, and in Ozempic, which is approved for type 2 diabetes. It works by acting on the GLP-1 hormone pathway to reduce appetite and slow stomach emptying, which helps people eat less. Treatment starts at a low dose and increases gradually over months to limit side effects. Average weight loss in trials has been meaningful, but individual results vary, and the medication works alongside nutrition and activity changes under physician supervision, not as a standalone fix.
How Does Semaglutide Cause Weight Loss?
Semaglutide mimics a natural gut hormone called GLP-1, which the body releases after eating. By acting on GLP-1 receptors, it increases feelings of fullness, reduces appetite and food cravings, and slows how quickly the stomach empties. The practical result is that people tend to feel satisfied with less food and think about food less, which lowers calorie intake without constant willpower. It also has effects on blood sugar regulation, which is why a closely related product treats diabetes.
This is a biological appetite change, not a stimulant or a fat burner. That distinction matters because it explains both why semaglutide works and why it works best paired with adequate protein, activity, and follow-up. For the full mechanism, see our guide on how GLP-1 medications work.
What Is the Semaglutide Dosing Schedule for Weight Loss?
For weight management, semaglutide (Wegovy) is started at a low dose and increased step by step over roughly four to five months until reaching the maintenance dose, with the highest weekly dose being 2.4 mg. The standard schedule moves through several intermediate doses, holding each for about four weeks before increasing, specifically to reduce gastrointestinal side effects. Not everyone reaches or stays at the top dose; a prescriber adjusts based on tolerance and response.
This slow ramp is the single most important tool for tolerability, which is why skipping ahead is discouraged. The exact steps and how they are individualized are covered in our semaglutide dosage chart guide. Your prescriber tailors the pace to you, sometimes holding longer at a dose if side effects are strong.
What Results Are Realistic with Semaglutide?
In clinical trials of semaglutide for weight management, participants lost a meaningful percentage of body weight on average over about a year and a half, alongside lifestyle support. That said, averages conceal a wide range: some people lose more, some less, and a minority respond minimally. Realistic expectations mean thinking in terms of a percentage of body weight over many months, not a fixed number on a fast timeline, and understanding that results depend on dose reached, adherence, and lifestyle changes.
Honesty here protects you from disappointment and from chasing the drug at the expense of safety. Results also depend on what happens long term, because weight tends to return if the medication is stopped without a maintenance plan, which we cover in what happens when you stop a GLP-1. A supervised program measures progress properly and adjusts the plan.
Who Is Semaglutide Appropriate For?
Semaglutide for weight management is generally appropriate for adults who meet specific body mass index criteria, either a BMI in the obesity range or in the overweight range with a weight-related health condition, and who do not have contraindications. A physician confirms eligibility, screens for contraindications like a personal or family history of certain thyroid cancers or pancreatitis, and reviews your other medications and conditions. It is not appropriate for everyone, and that screening is a core reason it requires a prescription.
Eligibility is a medical determination, not a self-assessment. For the criteria in plain terms, see our guide on who qualifies for GLP-1 weight loss medication. Ascend's medical weight loss program runs that evaluation and supervises treatment.
Care at Ascend: Learn more about Weight Loss at Ascend Mind and Body, or book an appointment.
Frequently asked questions
How fast does semaglutide work for weight loss?
Appetite changes can begin within the first weeks, but meaningful weight change unfolds over months as the dose is titrated up and lifestyle changes take hold. Trials measured results over roughly a year to a year and a half. Expecting fast, dramatic loss is unrealistic and can push people to escalate the dose unsafely; steady progress is the goal.
Do I need a prescription for semaglutide in Florida?
Yes. Semaglutide is a prescription medication in Florida and across the United States. A licensed clinician must evaluate you, confirm you meet the criteria, and supervise treatment with monitoring and follow-up. There is no legitimate way to obtain it without a prescription.
Can I get semaglutide for weight loss by telehealth in Florida?
Often, yes. Florida law allows a licensed clinician to establish care and prescribe by telehealth when the evaluation meets the standard of care. Whether semaglutide is appropriate for you, and whether it can be started remotely, depends on your history and labs. Ascend evaluates this case by case as part of its weight-loss program.
Will I regain the weight if I stop semaglutide?
Often, yes, at least partially, if the medication is stopped without a maintenance plan, because semaglutide treats the biology of appetite rather than permanently resetting it. Studies have shown weight regain after stopping. This is why a supervised program plans for the long term rather than treating the drug as a short course.
Medically reviewed by
Dr. Jason Saylor, DO
This article is for general educational purposes only and is not medical advice. It does not create a provider-patient relationship. Talk with a qualified Florida-licensed clinician about your individual situation.
Sources
- U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. accessdata.fda.gov.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021. nejm.org.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Prescription Medications to Treat Overweight and Obesity. niddk.nih.gov.